An injectable artificial bone compounded with microencapsulated artificial cells
An artificial cell and microencapsulation technology, applied in medical science, prosthesis, etc., can solve the problems of slow recovery and slow healing of bone wounds, and achieve the effects of alleviating pain, reducing trauma, and reducing the amount of internal fixation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0022] An injectable artificial bone compounded with microencapsulated artificial cells, comprising a solid phase component, a liquid phase component and a microencapsulated artificial cell component, the solid phase component comprising calcium carbonate, (-tricalcium phosphate and calcium hydrogen phosphate , the liquid phase component includes disodium hydrogen phosphate aqueous solution, the microencapsulated artificial cell component includes microbead capsules, and the microbead capsules are human bone marrow mesenchymal stem cells encapsulated by sodium alginate-polylysine-sodium alginate microcapsules Formed. After testing, the artificial bone of the present invention can be easily injected out by an injection needle with a length of 25cm and an inner diameter of 1.5mm, making it possible to adopt the minimally invasive method of percutaneous injection to fill the bone defect. pores, and the capsule wall of the microbead capsule has a certain compressive mechanical stre...
Embodiment 2
[0032] An injectable artificial bone compounded with microencapsulated artificial cells, comprising a solid phase component, a liquid phase component and a microencapsulated artificial cell component, the solid phase component including calcium carbonate, alpha-tricalcium phosphate and calcium hydrogen phosphate , calcium sulfate is also included in the solid phase component, and the mass percentages of calcium carbonate, α-tricalcium phosphate, calcium hydrogen phosphate and calcium sulfate in the solid phase component are respectively: calcium carbonate 10.4%, α-tricalcium phosphate 62.7% %, calcium dihydrogen phosphate 2.4% and calcium sulfate 20%;
[0033] The liquid phase components include disodium hydrogen phosphate aqueous solution and hydroxypropyl methylcellulose, and the mass concentrations of disodium hydrogen phosphate and hydroxypropyl methylcellulose in the liquid phase components are respectively: disodium hydrogen phosphate 28.4%, hydroxyl Propyl methylcellulo...
Embodiment 3
[0046] The above method of using the injectable artificial bone compounded with microencapsulated artificial cells, first mixes the liquid phase component and the microencapsulated artificial cell component, and then mixes them with the solid phase, quickly moves them into the syringe, and then passes through the corresponding injection needle It can be injected into the affected area, and the cement can be shaped arbitrarily during this period. After about 10 minutes, the artificial bone reaches the initial solidification, and at this time it cannot be shaped, otherwise it will break and affect the strength after curing. The final solidification is reached in about 15-20 minutes, and the artificial bone solidifies to a certain strength, and the wound can be sutured. The curing strength reaches its peak at 7 days, which is similar to the strength of cancellous bone. It can be applied to fractures and bone defects in metaphyseal cancellous bone, such as distal radius, proximal ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com